pamidronate has been researched along with trinitrobenzenesulfonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, JW; Lin, CL; Moniz, C | 1 |
| González, R; López-Posadas, R; Martínez-Augustin, O; Mascaraque, C; Sánchez de Medina, F; Suárez, MD; Zarzuelo, A | 1 |
2 other study(ies) available for pamidronate and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Treatment with fluoride or bisphosphonates prevents bone loss associated with colitis in the rat.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Diphosphonates; Disease Models, Animal; Inflammatory Bowel Diseases; Intestine, Large; Male; Osteoporosis; Pamidronate; Rats; Rats, Wistar; Sodium Fluoride; Tibia; Trinitrobenzenesulfonic Acid | 2000 |
The Bisphosphonate Pamidronate is an Intestinal Antiinflammatory Agent in Rat and Mouse Experimental Colitis.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Colitis; Dextran Sulfate; Diphosphonates; Ibandronic Acid; Immunologic Factors; Intestinal Mucosa; Mice; Pamidronate; Rats; T-Lymphocytes; Trinitrobenzenesulfonic Acid | 2016 |